Looking at Eli Lilly's Quarterly Sales data, International Growth has been very strong.
Q1: $1.2m
Q2: $1.6m
Q3: $1.8m
Year to date: $4.5m
The rate of growth is almost 25% on average per quarter, or by rough figures 100% yoy.
If Q4 comes in at $2m, then annually we're looking at $6.5m from International Sales. Lets say next year that same rate continues, we're now looking at around $11 - $13m in revenue per year from International markets - which is quite substantial.
It would be great to see more countries bolted on and rapid sales in these markets. Whilst the USA will most likely remain the most dominant market, its easy to forget that there is a big world outside of North America.
Add to My Watchlist
What is My Watchlist?
